GOLDENWELL BIOTECH, INC. (GWLL): auditor change — Goldenwell Biotech dismisses auditor Michael Gillespie & Associates, engages KCCW

GOLDENWELL BIOTECH, INC.

Dismissed Michael Gillespie & Associates on Jan 23, 2025; engagement lasted from Nov 14, 2024.
No disagreements on accounting principles, disclosure, or audit scope during the period.
Board approved dismissal and appointment of KCCW Accountancy Corp. as new independent auditor.
KCCW did not consult with company on accounting issues prior to engagement.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GOLDENWELL BIOTECH, INC. engaged KCCW Accountancy Corp. as its auditor.

Action: engagement
Auditor: KCCW Accountancy Corp.

Exact text from the filing

On January 23, 2025, the board of directors of the Company resolved to engage the independent registered public accounting firm KCCW Accountancy Corp. (“KCCW”), as the Company’s new independent registered public accountants, which appointment KCCW has accepted.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GOLDENWELL BIOTECH, INC. dismissed Michael Gillespie & Associates, PLLC as its auditor.

Action: dismissal
Auditor: Michael Gillespie & Associates, PLLC
Successor: KCCW Accountancy Corp.

Exact text from the filing

On January 23, 2025, Goldenwell Biotech, Inc. (the “Company”) notified Michael Gillespie & Associates, PLLC (“Michael Gillespie & Associates”) that the Company had dismissed Michael Gillespie & Associates as the independent registered public accounting firm of the Company.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

GOLDENWELL BIOTECH, INC. filing history →

Source: SEC EDGAR

accession 0001477932-25-000424

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.